Samen werken, voor een psychisch gezonde jeugd

Generic filters
Exact matches only


Agència d’Informació Avaluació I Qualitat en Salut (2011). Guía de práctica clínica sobre trastorno límite de la personalidad. Retrieved from

American Psychiatric Association. (2001). Practice guideline for the treatment of patients with borderline personality disorder. The American Journal of Psychiatry. 158(Suppl10):1–52.

Amminger P, Chanen AM, Ohmann S, Klier CM, Mossaheb N, Bechdolf A, Nelson B, Thompson A, McGorry P, Yung A & Schäfer M. (2013) Omega-3 Fatty Acid Supplementation in Adolescents With Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double-Blind, Randomized Controlled Trial. CanJPsychiatry. 58(7):402–408.

Argent S & Hill S (2014). The novel use of clozapine in an adolescent with borderline personality disorder. Ther Adv Psychopharmacol, 4(4):149-55. doi: 10.1177/2045125314532488.

Barnes RJ (1977). Mesoridazine in personality disorders – a controlled trial in adolescent patients. Diseases of the nervous system, 38:258-264.

Caihol L., Jeannot M, Rodgers R, Guelfi JD, Perez-Diaz F, Pham-Scottez A, Corcos M & Speranza M (2013). Borderline personality disorder and mental healthcare service use among adolescents. J Pers Disord, 27:252-259. Doi:10.1521/pedi.2013.27.2.252.

CBO (2008). Multidisciplinaire Richtlijn Persoonlijkheidsstoornissen. Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ. Trimbos instituut, Utrecht.

Chiesa M, Wright M & Leger D (2004). Psychotropic medication and the therapeutic community: a survey of prescribing practices for severe personality disorder. Therapeutic Communities, 25(2):131-144.

Golubchik P, Sever J, Zalsman G & Weizman A (2008). Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. International Clinical Psychopharmacology, 23:228–231.

GGZ Zorgstandaard Persoonlijkheidsstoornissen (2017). AKWA, Utrecht.

Ingenhoven T (2015). Pharmacotherapy for borderline patients: business as usual or by default? Journal of Clinical Psychiatry, 76 (4):522-523.

Ingenhoven T & Rinne T (2018). Farmacotherapie bij borderline-persoonlijkheidsstoornis: update 2018. Aanvullend hoofdstuk in In: Theo Ingenhoven, Han Berghuis, Sjoerd Colijn & Rien Van. Handboek persoonlijkheidsstoornissen. Utrecht, De Tijdstroom.

Kutcher S, Papatheodorou G, Reiter S & Gardner D (1995). The Successful Pharmacological Treatment of Adolescents and Young Adults with Borderline Personality Disorder: A Preliminary Open Trial of Flupenthixol. J Psychiatr Neurosci, 20(2):113-118.

Midgley, N., Holmes, J., Parkinson, S. e.a. (2014). “Just like talking to someone about like shit in your life and stuff, and they help you”: Hopes and expectations for therapy among depressed adolescents. Psychotherapy Research.

National Collaborating Centre for Mental Health (UK). Borderline Personality Disorder: Treatment and Management. Leicester (UK): British Psychological Society; 2009. PMID: 21796831

National Health and Medical Research Council (2013). Clinical Practice Guideline for the management of Borderline Personality DisorderRetrieved form

National Institute for Health and Care Excellence (2009). Borderline personality disorder: treatment and management (NICE clinical guideline 78). Retrieved from

Podobnik J, Foller Podobnik I, Grgic N, Marcinko D & Pivac N (2012). The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents. Psychopharmacology, 220:639–641. DOI 10.1007/s00213-011-2607-7.

Scalzo F, Hulbert CA, Betts JK, Cotton SM, Chanen AM. Substance Use in Youth With Borderline Personality Disorder. J Pers Disord. 2018 Oct;32(5):603-617.

Sundhedsstyrelsen (2015). Behandling af emotional ustabil personlighedsstruktur, borderline type. Retrieved from

Wöckel L, Goth K, Zepf FD, Matic N, Holtmann M, Herpertz-Dahlmann B & Poustka
F (2010). [Psychopharmacotherapy improves psychosocial functioning in adolescents with
borderline personality disorder] [Article in German]. Prax Kinderpsychol Kinderpsychiatr, 59(4):282-301. DOI: 10.13109/prkk.2010.59.4.282.

Farmacotherapeutisch Kompas 2020